Document:

Form of Restricted Stock Unit Agreement

 Exhibit 10.10 

 
  
 TERADYNE, INC. 2006 EQUITY AND CASH COMPENSATION INCENTIVE PLAN 
 NOTICE OF
RESTRICTED STOCK UNIT GRANT AND TERMS 
 FOR DIRECTOR AWARDS 

 
  
 Name 
 In granting restricted stock units, Teradyne seeks to provide employees, consultants
and/or directors with incentive to help drive the company’s future success and to share in the economic benefits of that success. We all look forward to your contributions to that effort. 

In recognition of your contributions to Teradyne, you have been granted an award consisting of the right to receive up to xxx shares of Teradyne common
stock. This grant was approved effective                          , 200x (the “Effective
Date”). 
 This award is subject to the Restricted Stock Unit Terms attached hereto and the terms of the Teradyne, Inc. 2006 Equity
and Cash Compensation Incentive Plan (the “Plan”). The shares covered by this award will be delivered over time as described in and subject to the vesting conditions of the Restricted Stock Unit Terms. 

The Plan prospectus, consisting of a “Participant Information” document that summarizes the Plan and contains a copy of the complete Plan, is
enclosed with this grant document. 
  

	
	TERADYNE, INC.
	
	/s/ Charles J. Gray
	Charles J. Gray
	V.P., General Counsel and Secretary

 (2006 RSU)

 Grant #xxx 
 Form of Director Grant
Agreement (2006 RSU) 

  
 RESTRICTED STOCK UNIT TERMS FOR DIRECTOR AWARDS 
 This award is governed by
and subject to Teradyne’s 2006 Equity and Cash Compensation Incentive Plan (the “Plan”), which, together with the following provisions, controls the meaning of terms and the rights of the recipient. Capitalized and defined terms used
and not defined below will have the meaning set forth in the Plan. In the event of any inconsistencies or differences between the Plan and these terms, the Plan shall prevail. 
 1. Award Grant, Vesting and Transfer 
 (a) Payment of par value.
Teradyne hereby grants to the recipient the right to receive that number of shares of Teradyne common stock as is set forth on the Notice of Restricted Stock Unit Grant attached hereto. When the underlying shares of Teradyne common stock are
issued to the recipient, par value will be deemed paid by the recipient for each share by past services rendered by the recipient. 
 (b) This award vests on the anniversary of the Effective Date. None of this grant will be vested on the Effective Date. 100% of the total grant will vest on the first anniversary of the
Effective Date. Subject to the terms of the Plan, the Teradyne Board of Directors shall have the right to accelerate the date that any installment of this award becomes vested in the event of disability, death, termination, retirement, or upon the
acquisition of control of Teradyne by another entity. 
 (c) This award will not vest further after termination of the
business relationship except in limited certain circumstances. This award will not vest after the recipient’s and Teradyne’s business relationship ends unless the Board accelerates the vesting pursuant to Paragraph 1(b) above;
provided that if the recipient’s business relationship with Teradyne ends on account of permanent disability or death, this award will vest automatically in full on the date the business relationship ends in the event of permanent
disability or death. 
 The business relationship with Teradyne shall be considered as continuing uninterrupted during any bona fide leave of
absence (such as those attributable to illness or military obligations) provided that the period of such leave does not exceed 90 days. A bona fide leave of absence with the written approval of the Committee shall not be considered an interruption
of the business relationship, provided that such written approval contractually obligates the Company to continue the business relationship of the recipient after the approved period of absence. 

(d) No rights as stockholder; Issuance. The recipient shall not have any right in, to or with respect to any
shares which may be covered by this award (including but not limited to the right to vote or to receive dividends) until the award is settled by issuance of shares to the recipient. All vested shares issued in respect of this award will be
transferred or issued to the recipient (or his or her estate, in the event of his or her death) promptly after the date they vest but in any event within
2 1/2 months following the calendar year in which
they become vested (or any earlier date, after vesting, required to avoid characterization as non-qualified deferred compensation under Section 409A of the Code). Teradyne will not be required to transfer or issue any vested shares until
arrangements satisfactory to it have been made to address any income, withholding and employment tax requirements which might arise by reason of the vesting and transfer or issuance of shares. 

(e) This award may not be assigned or transferred. Other than as provided in Section 11(a) of the Plan, this award is
not assignable or transferable (except by will or the laws of descent and distribution). 
 2. Capital Changes and Business
Succession. Section 3(c) of the Plan, contains provisions for adjusting the number, vesting schedule, exercise price and other terms of outstanding stock based Awards under the Plan if a recapitalization, stock split, merger, or other
specified event occurs and a Committee of the Board of Directors determines that an adjustment (or substitution) is appropriate. . In that event, the recipient of the award will be notified of the adjustment (or substitution), if any. 

3. Employment or Business Relationship. Granting this award does not imply any right of continued employment or business
relationship by the Company or a Related Corporation, and does not affect the right of the recipient or the Company or a Related Corporation to terminate employment or a business relationship at any time. 

4. Stock Registration. Shares to be issued under this award are currently registered under the Securities Act of 1933, as amended.
If such registration is not in effect at the time of vesting, the recipient will be required to represent to the Company that he or she is acquiring such shares as an investment and not with a view to the sale of those shares. 

5. Term. This Agreement will terminate on
                         , 20xx. 
 Form of Director Grant AgreementForm of Executive Officer Stock Option Agreement

 Exhibit 10.34 

 
  
 TERADYNE, INC. 2006 EQUITY AND CASH COMPENSATION INCENTIVE PLAN 
 NOTICE OF STOCK
OPTION GRANT AND TERMS 
  
  

 

			
	 Name
	  	 Employee ID:

		
	 Division:

Supervisor:
 Location:
	  	

 In granting stock options, Teradyne seeks to provide employees with incentive to help drive the company’s
future success and to share in the economic benefits of that success. We all look forward to your contributions to that effort. 
 In
recognition of your contributions to Teradyne, you have been granted a stock option award consisting of the right to receive up to XX shares of Teradyne common stock upon exercise of this option in accordance with its terms (“Stock
Option”). This Stock Option grant was approved effective                          , 200x (the
“Effective Date”). The Stock Option Grant Details are listed below. 
 This award is subject to the Stock Option Terms
attached hereto and the terms of the Teradyne, Inc. 2006 Equity and Cash Compensation Incentive Plan (the “Plan”). Stock Options covered by this award will be exercisable over time as described in and subject to the vesting
conditions of the attached Stock Option Terms. 
 The Plan prospectus, consisting of a “Participant Information” document that
summarizes the Plan and the complete Plan, is available on “In-Site,” Teradyne’s internal Web site. To access the information, go to
http://cms.corp.teradyne.com/insite/FunctionsGroups/GeneralAdministrative/HumanResources/Benefits/USBenefits/FinancialBenefits/P_023923. 

Please note that printed versions of the Plan prospectus documents are available to you, at no charge, upon request to HR Service Center, Teradyne, Inc.,
600 Riverpark Drive, North Reading, MA 01864, (978) 370-3041. 
  

			
		 	TERADYNE, INC.
	Stock Option Grant Details:	 	
	Grant Date/Effective Date:
[                            , 2010]	 	
	Number of Shares under Option:
[                            ]	 	
	Per Share Option Price/FMV on Grant
Date:[                    ]	 	
		 	/s/ Charles J. Gray
		 	Charles J. Gray
		 	V.P., General Counsel and Secretary

 (2010 Stock Option)

 Grant #XX 
 Executive Officer SO
Grant Form 

  
 STOCK OPTION TERMS 
 This award is governed by and subject to
Teradyne’s 2006 Equity and Cash Compensation Incentive Plan (the “Plan”), which, together with the following provisions, controls the meaning of terms and the rights of the recipient. Capitalized and defined terms used and not
defined below will have the meaning set forth in the Plan. In the event of any inconsistencies or differences between the Plan and these terms, the Plan shall prevail. 
  

	 	1.	Option Grant, Exercise and Vesting 

  

	 	(a)	This Stock Option is intended to be a nonstatutory stock option. 

 (b) These options vest and become exercisable yearly on the anniversary of the Effective Date. None of this grant will be vested or exercisable on the Effective Date. 25% of the total grant will
vest and become exercisable on the first and each of the three subsequent anniversaries of the Effective Date until the total grant is fully vested and exercisable on the fourth anniversary of the Effective Date. The committee appointed by
Teradyne’s Board of Directors to administer the Plan (the “Committee”) shall have the right at any time to accelerate the date that any installment of this award becomes vested and exercisable, including but not limited to
events such as disability, death, retirement or upon the acquisition of control of Teradyne by another entity. 
 (c) After
options become exercisable, they can be exercised at any time prior to and on the Option Expiration Date. This Stock Option expires at the close of business at the Company’s headquarters on the date that is seven years from the
Effective Date (the “Option Expiration Date”). This Stock Option may expire earlier if your employment or other business relationship terminates, as described below. 
 (d) This stock option award will not vest further after termination of employment or other business relationship except in limited certain circumstances. If your employment or business relationship
terminates for any reason except disability or death, then this stock option will not vest after your employment or other business relationship ends and this stock option will automatically expire at the close of business at the Company’s
headquarters on the date ninety (90) days after your termination date, or if earlier, the Option Expiration Date. If your employment or other business relationship with the Company ends on account of permanent disability or death, that
portion of this award which would have vested under the applicable rule stated in (b) above shall automatically become vested in full on the date of your termination of employment or business relationship on account of permanent disability or
death and the vested portion of this stock option may be exercised in accordance with Section 11(a) of the Plan until the earlier of the close of business at the Company’s headquarters on the date that is one year subsequent to your
termination due to permanent disability or death or the Option Expiration Date. 
 Employment or another business relationship shall be
considered as continuing uninterrupted during any bona fide leave of absence (such as those attributable to illness or military obligations) provided that the period of such leave does not exceed 90 days or, in the case of an employee, if longer,
any period during which the employee’s right to reemployment is guaranteed by statute. A bona fide leave of absence with the written approval of the Committee shall not be considered an interruption of employment or other business relationship,
provided that such written approval contractually obligates the Company to continue the employment or other business relationship of the recipient after the approved period of absence. 

 

	 	2.	Procedure for Exercising Options 

 (a) Options are exercised by giving written notice to the Company specifying the number of shares as to which Option is being exercised and paying the Company the full option price for such shares.
Payment can be made to the Company by a combination of cash, certified or bank check, or personal check (in each case in United States dollars), or by delivery of shares of Teradyne common stock that were not acquired in the 6 months prior to
exercise of the option or through the delivery of an assignment to the Company of a sufficient amount of the proceeds from the sale of the common stock acquired upon exercise of the Option and authorization to the third party commercial provider to
pay that amount to the Company, provided the such process is consistent with and permissible under applicable law. 
 Executive Officer Stock
Option Grant Form 

 (b) You shall not have any right in, to or with respect to the shares
which may be issuable under this award upon exercise (including but not limited to the right to vote or to receive dividends) until the issuance of shares to you upon exercise of the option. All shares issuable upon exercise of this option will be
transferred or issued to you (or your estate, in the event of your death) promptly upon exercise but in any event within 2 1/2 months following the calendar year in which they are exercised, or any earlier date required to avoid characterization as non-qualified deferred compensation under
Section 409A of the Code). 
 (c) With regard to any option exercises, the Company will not be required to transfer
or issue any shares until arrangements satisfactory to it have been made to address any income, withholding and employment tax requirements which might arise by reason of the option exercise. The Company will pay any transfer or issue tax and
deliver a certificate for the shares purchased. 
  

	 	3.	Assignment and Transferability 

 This stock option award may not be assigned or transferred other than as provided in Section 11(a) of the Plan. 
  

	 	4.	Capital Changes and Business Succession 

 Section 3(c) of the Plan contains provisions for adjusting (or substituting) the number, vesting schedule, exercise, price and other terms of outstanding stock-based Awards granted under the Plan if
a recapitalization, stock split, merger, or other specified event occurs, and the Committee determines that an adjustment (or substitution) is appropriate. 
  

	 	5.	Employment or Business Relationship 

 Granting this award does not imply any right of continued employment or business relationship by the Company, and does not affect the right of the recipient or the Company to terminate employment or a
business relationship at any time. 
  

	 	6.	Stock Registration 

Shares to be issued upon exercise of this option are currently registered under the Securities Act of 1933, as amended. If such
registration is not in effect at the time of exercise, the recipient will be required to represent to the Company that he or she is acquiring such shares as an investment and not with a view to the sale of those shares. 

 

	 	7.	Miscellaneous: 

 This
Stock Option Award is governed by and interpreted in accordance with the laws of the Commonwealth of Massachusetts exclusive of reference of rules and principles of conflicts of law. This Stock Option Award and the Plan constitute the entire
understanding between you and the Company regarding this option. 
 Executive Officer SO Grant Form

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]